CDC issues Level 1 travel notice for Bundibugyo virus in Uganda
The US Centers for Disease Control and Prevention has released a Level 1 travel health notice for Uganda, citing an ongoing outbreak of Bundibugyo virus disease.
The US Centers for Disease Control and Prevention has issued a Level 1 travel health notice for Uganda, advising travellers to practice usual precautions. The alert follows the confirmation of an outbreak of Bundibugyo virus disease, a rare subtype of Ebola caused by the Bundibugyo virus.
Under the CDC’s classification system, a Level 1 notice represents the lowest level of travel health alert. This designation indicates that standard hygiene and safety measures are sufficient for most travellers, rather than requiring significant changes to travel plans or enhanced protective equipment.
Bundibugyo virus disease is a distinct form of Ebola virus disease. While it shares characteristics with other strains, it is caused specifically by the Bundibugyo virus. The CDC’s advisory focuses on this particular outbreak within Uganda, distinguishing it from other Ebola activity in the region.
The broader regional context includes concurrent Ebola activity in the Democratic Republic of the Congo. The Africa Centres for Disease Control and Prevention confirmed an outbreak in the Northeastern Ituri province, driven by an uncommon strain that differs from the typical Zaire ebolavirus. This divergence has raised concerns among experts regarding the efficacy of current licensed vaccines and treatments, which were developed specifically for the Zaire strain.
The World Health Organization has responded to the situation in the Democratic Republic of the Congo by deploying a team and releasing emergency funds. However, the CDC’s current notice remains specific to the Bundibugyo virus disease outbreak in Uganda, where the primary guidance is to maintain usual precautions.
The source material does not specify the number of confirmed cases, the precise geographic location of the outbreak within Uganda, or the timeline of the initial cases. It remains unclear if the Bundibugyo strain in Uganda is genetically distinct from previous outbreaks or represents a re-emergence of a known lineage.
